ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,275,603 | -42.3% | 39,194 | -46.5% | 0.00% | -100.0% |
| Q2 2023 | $3,941,163 | +47.8% | 73,215 | +9.0% | 0.00% | 0.0% |
| Q1 2023 | $2,667,159 | -8.4% | 67,149 | -7.2% | 0.00% | 0.0% |
| Q4 2022 | $2,912,089 | -2.2% | 72,386 | -21.9% | 0.00% | 0.0% |
| Q3 2022 | $2,977,000 | -26.1% | 92,626 | -31.8% | 0.00% | 0.0% |
| Q2 2022 | $4,029,000 | +817.8% | 135,809 | +768.8% | 0.00% | – |
| Q1 2022 | $439,000 | -75.1% | 15,631 | -59.1% | 0.00% | – |
| Q4 2021 | $1,760,000 | -82.8% | 38,195 | -87.7% | 0.00% | -100.0% |
| Q3 2021 | $10,216,000 | -19.4% | 311,262 | -14.0% | 0.00% | -33.3% |
| Q2 2021 | $12,679,000 | +3.7% | 361,744 | +6.9% | 0.00% | 0.0% |
| Q1 2021 | $12,228,000 | +22.9% | 338,368 | -1.2% | 0.00% | 0.0% |
| Q4 2020 | $9,947,000 | +12.9% | 342,528 | +9.7% | 0.00% | 0.0% |
| Q3 2020 | $8,809,000 | -0.5% | 312,259 | +14.0% | 0.00% | 0.0% |
| Q2 2020 | $8,857,000 | -22.7% | 273,859 | -2.7% | 0.00% | -25.0% |
| Q1 2020 | $11,465,000 | -33.3% | 281,421 | +1.0% | 0.00% | 0.0% |
| Q4 2019 | $17,189,000 | +4.8% | 278,730 | +23.8% | 0.00% | -20.0% |
| Q3 2019 | $16,409,000 | +331.4% | 225,153 | +386.5% | 0.01% | +400.0% |
| Q2 2019 | $3,804,000 | -2.3% | 46,278 | -16.2% | 0.00% | 0.0% |
| Q1 2019 | $3,895,000 | +66.9% | 55,213 | +6.5% | 0.00% | 0.0% |
| Q4 2018 | $2,334,000 | -60.6% | 51,838 | -50.6% | 0.00% | -50.0% |
| Q3 2018 | $5,931,000 | -5.7% | 104,904 | +11.4% | 0.00% | 0.0% |
| Q2 2018 | $6,290,000 | +31.3% | 94,154 | +14.4% | 0.00% | +100.0% |
| Q1 2018 | $4,792,000 | +110.7% | 82,298 | +133.3% | 0.00% | 0.0% |
| Q4 2017 | $2,274,000 | -0.3% | 35,280 | -18.8% | 0.00% | 0.0% |
| Q3 2017 | $2,281,000 | +200.1% | 43,466 | +167.6% | 0.00% | – |
| Q2 2017 | $760,000 | -25.4% | 16,243 | -21.1% | 0.00% | – |
| Q1 2017 | $1,019,000 | -28.7% | 20,579 | -12.8% | 0.00% | – |
| Q4 2016 | $1,430,000 | +71.1% | 23,593 | +87.2% | 0.00% | – |
| Q3 2016 | $836,000 | +56.3% | 12,606 | +31.5% | 0.00% | – |
| Q2 2016 | $535,000 | 0.0% | 9,588 | -39.7% | 0.00% | – |
| Q1 2016 | $535,000 | -4.8% | 15,889 | +27.6% | 0.00% | – |
| Q4 2015 | $562,000 | +47.9% | 12,457 | +29.6% | 0.00% | – |
| Q3 2015 | $380,000 | -78.9% | 9,609 | -66.9% | 0.00% | -100.0% |
| Q2 2015 | $1,803,000 | +59.4% | 29,061 | +60.7% | 0.00% | – |
| Q1 2015 | $1,131,000 | +8.8% | 18,089 | -40.1% | 0.00% | – |
| Q2 2014 | $1,040,000 | +301.5% | 30,201 | +266.1% | 0.00% | – |
| Q1 2014 | $259,000 | – | 8,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |